Search results
8 lut 2021 · Visceral adipose tissue (VAT) are deleterious fat deposits in the human body and can be effectively reduced by exercise intervention. Despite well-established exercise prescriptions are...
- Metrics
Chętnie wyświetlilibyśmy opis, ale witryna, którą oglądasz,...
- Review Articles
Browse the archive of articles on International Journal of...
- RSS Feed
The International Journal of Obesity is a multi-disciplinary...
- Sign up for Alerts
Chętnie wyświetlilibyśmy opis, ale witryna, którą oglądasz,...
- Current Issue
Sex-specific association of visceral and subcutaneous...
- Metrics
3 sie 2021 · Visceral and ectopic fat are key drivers of adverse cardiometabolic outcomes in obesity. We aimed to evaluate the effects of injectable liraglutide 3·0 mg daily on body fat distribution in adults with overweight or obesity without type 2 diabetes at high cardiovascular disease risk.
Randomized controlled trials (RCTs) of GLP-1Ras was extracted, including reports of effects on visceral adipose tissue and hepatic fat content in individuals with type 2 diabetes, non-type 2 diabetes, NAFLD (non-alcoholic fatty liver disease), and non-NAFLD. Meta-analyses used random-effects models. Results
These results suggest that an aerobic exercise program, without hypocaloric diet, can show beneficial effects to reduce visceral adipose tissue with more than 30 cm 2 (on CT analysis) in women and more than 40 cm 2 in men, even after 12 weeks.
Visceral adipose tissue (VAT) accumulation is associated with multiple cardiovascular disease (CVD) risk factors, including hypertension, impaired fasting glucose, type 2 diabetes, and metabolic syndrome [ 1 ].
1 lut 2019 · The adverse cardiometabolic effects of obesity are well described, with a growing recognition that visceral adipose tissue (VAT) is a key contributor to the pathogenesis of the metabolic syndrome. 1 Accumulation of VAT is also associated with an increased risk of cardiovascular disease, 2 type 2 diabetes, 3 and cancer. 4
Optimal management of preobesity/obesity involves assessing and understanding the clinical importance of visceral adipose tissue (VAT) (adipose tissue surrounding intra-abdominal body organs) and android fat (abdominal subcutaneous adipose tissue [SAT] plus VAT).